Gastrointestinal and metabolic effects of amylase inhibition in diabetics
- 1 February 1988
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 94 (2) , 387-394
- https://doi.org/10.1016/0016-5085(88)90426-x
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humansGastroenterology, 1986
- Colonic metabolism of wheat starch in healthy humansGastroenterology, 1986
- Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humansGastroenterology, 1985
- Phytohemagglutinin-induced diarrheal diseaseDigestive Diseases and Sciences, 1984
- Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studiesThe American Journal of Clinical Nutrition, 1983
- A Bean α-Amylase Inhibitor Formulation (Starch Blocker) Is Ineffective in ManScience, 1983
- "STARCH BLOCKERS" ARE INEFFECTIVE IN MANThe Lancet, 1983
- Starch Blockers — Their Effect on Calorie Absorption from a High-Starch MealNew England Journal of Medicine, 1982
- SUCROSE MALABSORPTION IN MAN AFTER INGESTION OF α-GLUCOSIDEHYDROLASE INHIBITORThe Lancet, 1978
- Relations between Pancreatic Enzyme Outputs and Malabsorption in Severe Pancreatic InsufficiencyNew England Journal of Medicine, 1973